- Home
- Publications
- Publication Search
- Publication Details
Title
Current and Emerging Targets in Immunotherapy for Osteosarcoma
Authors
Keywords
-
Journal
Journal of Oncology
Volume 2019, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2019-01-02
DOI
10.1155/2019/7035045
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse
- (2018) Bingxin Zheng et al. Journal of Hematology & Oncology
- Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
- (2018) Fabio Conforti et al. LANCET ONCOLOGY
- Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases
- (2018) Pooja Dhupkar et al. Cancer Medicine
- Current status of immunotherapy for sarcomas
- (2017) Shinji Miwa et al. Immunotherapy
- Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
- (2017) Hussein A Tawbi et al. LANCET ONCOLOGY
- Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2
- (2017) Cristina Meazza et al. MEDICAL ONCOLOGY
- MAP plus maintenance pegylated interferon α-2b (MAPIfn) versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 “good response” randomization.
- (2017) Stefan S. Bielack et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas
- (2016) M. S. Merchant et al. CLINICAL CANCER RESEARCH
- In vitro generation of cytotoxic T lymphocyte response using dendritic cell immunotherapy in osteosarcoma
- (2016) Ye-Teng He et al. Oncology Letters
- Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
- (2015) Nabil Ahmed et al. JOURNAL OF CLINICAL ONCOLOGY
- Dendritic cells combined with anti-GITR antibody produce antitumor effects in osteosarcoma
- (2015) MASANORI KAWANO et al. ONCOLOGY REPORTS
- Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma
- (2015) Danielle M Lussier et al. Journal for ImmunoTherapy of Cancer
- Increased CTLA-4+ T cells and an increased ratio of monocytes with loss of class II (CD14+ HLA-DRlo/neg) found in aggressive pediatric sarcoma patients
- (2015) Pooja Hingorani et al. Journal for ImmunoTherapy of Cancer
- Expression of programmed death 1 is correlated with progression of osteosarcoma
- (2014) Wenjie Zheng et al. APMIS
- A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
- (2014) P. F. Robbins et al. CLINICAL CANCER RESEARCH
- Regulatory T cells in cancer immunotherapy
- (2014) Hiroyoshi Nishikawa et al. CURRENT OPINION IN IMMUNOLOGY
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- Immune-based therapies for childhood cancer
- (2014) Crystal L. Mackall et al. Nature Reviews Clinical Oncology
- Myeloid-Derived Suppressor Cells in Cancer: Therapeutic, Predictive, and Prognostic Implications
- (2014) C. Marcela Diaz-Montero et al. SEMINARS IN ONCOLOGY
- Programmed Cell Death Ligand 1 Expression in Osteosarcoma
- (2014) J. K. Shen et al. Cancer Immunology Research
- Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression
- (2014) Damya Laoui et al. Frontiers in Immunology
- Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients
- (2013) Ryuji Takahashi et al. CANCER SCIENCE
- Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma
- (2013) MASANORI KAWANO et al. ONCOLOGY REPORTS
- WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition
- (2013) Vickie Y. Jo et al. PATHOLOGY
- Immunotherapy of cancer in 2012
- (2012) John M. Kirkwood et al. CA-A CANCER JOURNAL FOR CLINICIANS
- SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: A study from the Japanese Musculoskeletal Oncology Group
- (2012) Satoshi Kawaguchi et al. CANCER SCIENCE
- Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma
- (2012) Nourredine Himoudi et al. Clinical & Translational Oncology
- Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological Effects and Clinical Activity
- (2012) J. Karbach et al. CLINICAL CANCER RESEARCH
- How Much of a Good Thing? What Duration for Interferon Alfa-2b Adjuvant Therapy?
- (2012) Ahmad A. Tarhini et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- Cryoimmunologic Antitumor Effects Enhanced by Dendritic Cells in Osteosarcoma
- (2010) Masanori Kawano et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- A TCR Targeting the HLA-A*0201-Restricted Epitope of MAGE-A3 Recognizes Multiple Epitopes of the MAGE-A Antigen Superfamily in Several Types of Cancer
- (2010) N. Chinnasamy et al. JOURNAL OF IMMUNOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma
- (2009) Alexander J. Chou et al. CANCER
- The role of interferons in the treatment of osteosarcoma
- (2009) Jeremy Whelan et al. PEDIATRIC BLOOD & CANCER
- Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group
- (2008) Paul A. Meyers et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started